Almanac A1C

Breaking the Fast: Meal Sequencing Strategies for Optimal Postprandial Glucose Control and Safe Refeeding

Posted

by

A1C Medical Team

Table of Contents
Keywords: , , , , , , , , , , , , , , , ,

Introduction

The global prevalence of metabolic disorders, including type 2 diabetes mellitus (T2DM), prediabetes, and metabolic syndrome, continues to escalate worldwide [1]. Approximately 37% of adults in the United States exhibit prediabetes, with projections indicating continued growth in this population [2]. Concurrently, intermittent fasting has gained significant attention as a therapeutic intervention.

Traditional dietary interventions have focused primarily on macronutrient composition and caloric restriction. However, emerging evidence suggests that when and in what order foods are consumed may be equally important as what is consumed [3, 4]. This paradigm shift has led to increased interest in meal sequencing strategies and optimized refeeding protocols following fasting periods.

The physiological rationale for these approaches centers on the complex interplay between gastric emptying, incretin hormone secretion, and postprandial glucose homeostasis [5–7]. Understanding these mechanisms provides the foundation for evidence-based interventions that can be readily implemented in clinical practice.

Physiological Mechanisms of Meal Sequencing

Gastric Emptying and Nutrient Absorption

Gastric emptying represents a critical regulatory checkpoint in postprandial metabolism. The stomach functions as a controlled reservoir, releasing chyme into the duodenum at an average rate of 1-4 kcal/min [8, 9], with emptying patterns varying significantly based on meal composition and volume. Liquids empty more rapidly than solids, while high-energy foods demonstrate prolonged gastric residence times compared to low-energy alternatives [9, 10].

The physical properties of ingested foods create a hierarchical emptying pattern. Fiber-rich vegetables form viscous gels that delay gastric emptying through mechanical mechanisms, while proteins and fats trigger the release of cholecystokinin (CCK) and other satiety hormones that further slow gastric transit [11–13]. This coordinated response creates an opportunity for strategic meal sequencing to modulate nutrient delivery to the small intestine [14].

Incretin Hormone Response

The incretin system, comprising primarily glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), represents the primary hormonal mechanism mediating the beneficial effects of meal sequencing [15]. These hormones are secreted from intestinal L-cells and K-cells [16, 17], respectively, in response to nutrient exposure.

GLP-1 demonstrates multiple glucoregulatory effects: glucose-dependent insulin secretion enhancement, glucagon suppression, delayed gastric emptying, and central appetite regulation [15, 18, 19]. The hormone’s glucose-dependent action profile provides inherent safety, as its insulinotropic effects diminish when glucose levels normalize [17]. GIP similarly enhances insulin secretion but also promotes nutrient storage in adipose tissue, particularly in response to fat intake [17].

The relative contributions of GLP-1 and GIP vary with meal composition. Carbohydrate-rich meals preferentially stimulate GLP-1 secretion, while mixed meals containing fats activate both incretin pathways [20–22]. This differential response underlies the mechanistic rationale for consuming non-carbohydrate components before carbohydrates, allowing incretin-mediated protective effects to be established prior to glucose absorption.

Metabolic Switching and Substrate Utilization

During fasting states, the body undergoes metabolic switching from glucose-dependent to fat-dependent energy metabolism [23–25]. This transition involves depletion of hepatic glycogen stores (typically within 12-24 hours), followed by increased lipolysis and ketone production [25, 26]. The metabolic flexibility achieved through this switching process appears to confer multiple health benefits, including improved insulin sensitivity, enhanced autophagy, and reduced oxidative stress [27–29].

The preservation of this metabolic state during refeeding requires careful attention to macronutrient selection and timing. Rapid carbohydrate intake can precipitate an abrupt return to glycolytic metabolism, potentially negating many of the benefits achieved during the fasting period [30–32].

Clinical Evidence for Meal Sequencing Strategies

Vegetables and Fiber First: The Foundation Strategy

Multiple randomized controlled trials have demonstrated the efficacy of initiating meals with fiber-rich vegetables. Shukla et al. [2] conducted a seminal crossover study in 15 participants with prediabetes, comparing three meal orders: carbohydrate-first (CF), protein/vegetables-first (PVF), and vegetables-first (VF). Both PVF and VF meal orders reduced incremental glucose peaks by more than 40% compared to CF, with the VF condition requiring the least insulin response while achieving similar glucose control.

A 2024 randomized crossover trial in healthy UAE adults (n=18) demonstrated that consuming vegetables and protein before carbohydrates (VPF sequence) reduced postprandial glucose incremental area under the curve by 40.9% and insulin AUC by 31.7% compared to a standard mixed meal [33]. The VPF sequence also enhanced satiety, with participants reporting greater fullness at 60 and 120 minutes post-meal.

The fiber preload mechanism operates through both physical and biochemical pathways. Soluble fiber forms viscous gels that mechanically impede carbohydrate digestion and absorption. Additionally, fiber fermentation by gut microbiota produces short-chain fatty acids that enhance insulin sensitivity and glucose homeostasis [34, 35].

Protein and Fat Integration: The Second Course

The strategic consumption of protein and healthy fats as a second course leverages multiple physiological mechanisms. Protein stimulates GLP-1 secretion more potently than other macronutrients [36], with whey protein demonstrating particularly strong effects [37–39]. A study by Ma et al. showed that 55g of whey protein consumed before carbohydrates increased GLP-1 by 141% and reduced postprandial glucose excursions by 36% in individuals with T2DM [40].

Healthy fats, particularly monounsaturated fats, contribute to this effect through CCK stimulation and delayed gastric emptying. A 30 mL olive oil preload has been shown to delay gastric emptying by 40% and reduce postprandial glucose peaks by 28% in T2DM patients [41]. However, the type of fat consumed appears critical, as saturated fats may promote GIP-mediated lipid storage, potentially counteracting long-term metabolic benefits [42–44].

Carbohydrates Last: Optimizing the Final Component

The consumption of carbohydrates as the final meal component allows the protective effects of fiber, protein, and fat to be fully established before glucose absorption begins. This approach has demonstrated consistent benefits across diverse populations and meal compositions.

A Japanese study utilizing continuous glucose monitoring found that consuming non-rice components (fish, vegetables) 5-15 minutes before rice reduced 4-hour postprandial glucose by 12-25% compared to traditional mixed consumption patterns [45]. Importantly, even a 5-minute interval between non-carbohydrate and carbohydrate consumption was sufficient to activate beneficial incretin pathways [46].

The quality of carbohydrates consumed also influences outcomes. Low-glycemic-index carbohydrates (GI <55) demonstrate superior postprandial glucose profiles compared to high-GI alternatives [47–49]. Traditional sourdough bread represents a notable exception among grain-based carbohydrates, as the fermentation process reduces glycemic impact through bacterial pre-digestion of starches and production of organic acids that modulate glucose absorption [50, 51].

Apple Cider Vinegar: Evidence for Pre-Meal Supplementation

Mechanisms of Action

Apple cider vinegar (ACV), composed primarily of acetic acid and polyphenolic compounds, demonstrates multiple mechanisms relevant to glucose homeostasis. Acetic acid inhibits disaccharidase activity in the small intestine, slowing carbohydrate digestion and reducing glucose absorption rates. Additionally, acetic acid enhances hepatic glucose uptake through AMPK (AMP-activated protein kinase) activation, promoting glucose utilization over storage [52, 53].

The polyphenolic components of ACV contribute antioxidant effects that may ameliorate postprandial oxidative stress. This is particularly relevant given that postprandial hyperglycemia generates reactive oxygen species that contribute to endothelial dysfunction and accelerated atherosclerosis [52, 53].

Clinical Efficacy Data

A comprehensive 2025 meta-analysis of seven controlled trials examining ACV supplementation in T2DM patients revealed significant benefits across multiple glycemic parameters. ACV consumption reduced fasting blood glucose by 21.9 mg/dL (95% CI: -29.19 to -14.67, p<0.001) and HbA1c by 1.53% (95% CI: -2.65 to -0.41, p=0.008). A dose-response relationship was identified, with each 1 mL/day increase in ACV consumption associated with a 1.255 mg/dL reduction in fasting blood glucose [53].

The optimal dosing regimen appears to be 5-15 mL of ACV diluted in water, consumed 15-30 minutes before meals. Higher doses (>15 mL) did not demonstrate proportionally greater benefits and may increase the risk of gastrointestinal irritation or dental enamel erosion [52, 53].

Safety Considerations

ACV supplementation demonstrates an excellent safety profile when used appropriately. However, several precautions warrant attention. Undiluted ACV should be avoided due to its potential for dental enamel erosion and esophageal irritation. Individuals taking medications that affect potassium levels (diuretics, ACE inhibitors) should consult healthcare providers before initiating ACV supplementation, as acetic acid may enhance potassium excretion [52].

Intermittent Fasting and Protein Pacing: Synergistic Approaches

The Protein Pacing Protocol

Protein pacing involves consuming four high-protein meals (25-50g protein each) evenly distributed throughout the eating window, typically spaced 3-4 hours apart [54]. This approach leverages the thermogenic effect of protein, which requires 20-30% of consumed calories for digestion and metabolism, compared to 5-10% for carbohydrates and 0-3% for fats [55].

A landmark 2024 study published in Nature Communications compared intermittent fasting with protein pacing (IF-P) to continuous calorie restriction in 41 overweight/obese participants. The IF-P group consumed 35% protein, 35% carbohydrates, and 30% fat, while the control group followed a heart-healthy diet with 21% protein, 41% carbohydrates, and 38% fat. Despite equivalent caloric intake, the IF-P group achieved superior weight loss (8.81% vs. 5.4% body weight) and demonstrated enhanced body composition changes [54].

Gut Microbiome Implications

The IF-P protocol demonstrated profound effects on gut microbiome composition, increasing beneficial bacteria such as Christensenellaceae, which are associated with lean body phenotypes and improved metabolic health [54, 56, 57]. These microbiome changes correlated with improved gastrointestinal symptoms and enhanced diversity indices.

The gut microbiome changes observed with IF-P may contribute to the protocol’s metabolic benefits through multiple pathways: enhanced short-chain fatty acid production, improved intestinal barrier function, reduced systemic inflammation, and optimized bile acid metabolism [54, 58]. These effects represent an additional mechanism beyond the direct metabolic benefits of intermittent fasting and protein pacing.

Long-term Adherence and Sustainability

One critical advantage of the IF-P approach is its potential for long-term adherence. A 2025 case study documented successful maintenance of 100-pound weight loss over two years using IF-P protocols. The flexibility inherent in intermittent fasting approaches, combined with the satiety benefits of high protein intake, may contribute to superior long-term compliance compared to traditional continuous calorie restriction [59].

Safe Refeeding Protocols: Breaking Fasts Appropriately

Physiological Considerations During Fasting

Extended fasting periods (>24 hours) result in significant physiological adaptations that must be considered during refeeding. Digestive enzyme production decreases, gastric acid secretion diminishes [60–62] , and the gastrocolic reflex becomes attenuated [63, 64]. These changes create vulnerability during the refeeding period, necessitating a graduated approach to food reintroduction.

The duration of fasting influences the complexity of required refeeding protocols. Short-term fasts (<24 hours) require minimal special considerations, while extended fasts (>72 hours) mandate careful attention to prevent refeeding syndrome, a potentially life-threatening condition characterized by severe electrolyte shifts [32, 65–67].

Refeeding Syndrome: Recognition and Prevention

Refeeding syndrome occurs when rapid carbohydrate intake after prolonged fasting triggers massive insulin release, leading to intracellular shifts of phosphorus, potassium, and magnesium [30, 32, 67]. This condition is most likely in malnourished individuals or those who have experienced significant weight loss (>10-15% body weight in 3-6 months) [68].

Prevention strategies include: gradual food reintroduction at 50% or less of normal intake initially, avoidance of high-carbohydrate foods during the first 24-48 hours of refeeding, supplementation with thiamine, phosphorus, potassium, and magnesium as indicated, and close monitoring of electrolyte levels in high-risk individuals.

Structured Refeeding Protocol

Based on the available evidence and uploaded protocols, we recommend a three-phase approach to breaking fasts:

Phase 1 (0-2 hours): Initial Refeeding

  • Optional: 5-10 mL apple cider vinegar diluted in water, consumed 15-30 minutes before food
  • Bone broth (rich in glycine, electrolytes, and easily digestible proteins)
  • Small amounts of healthy fats (olive oil, avocado)
  • Minimal portions of fermented foods (sauerkraut, kimchi) for microbiome support

Phase 2 (2-4 hours): Secondary Refeeding

  • Complete proteins in small portions (eggs, fish, grass-fed meat)
  • Low-carbohydrate vegetables (leafy greens, cruciferous vegetables)
  • Additional healthy fats (nuts, seeds)
  • Continued hydration with water or herbal teas

Phase 3 (4+ hours): Complete Refeeding

  • Complex carbohydrates in limited quantities (whole grains, legumes)
  • Expanded variety of proteins and fats
  • Low-glycemic fruits (berries) if desired
  • Traditional sourdough bread, if carbohydrates are desired

Duration-Specific Modifications

  • Short-term Fasts (16-24 hours): The protocol can be simplified, beginning with protein and healthy fats before introducing carbohydrates. The protein pacing approach may be particularly beneficial for daily intermittent fasting practitioners.
  • Extended Fasts (24-72 hours): Require more gradual progression, with initial consumption limited to broths and easily digestible proteins. Carbohydrates should be avoided for at least 6-12 hours post-fast.
  • Prolonged Fasts (>72 hours): Mandate medical supervision and extremely gradual refeeding. The Protein-Sparing Modified Fast (PSMF) model provides useful guidance, emphasizing 1.2-1.5g protein per kg goal body weight while severely limiting carbohydrates (20-50g daily) for the first 48-72 hours.

Clinical Implementation and Practical Considerations

  • Patient Selection and Individualization
    The evidence supports meal sequencing and structured refeeding protocols across diverse populations, including healthy individuals, those with prediabetes, and patients with established T2DM. However, certain populations require modified approaches:
  • Patients with gastroparesis or delayed gastric emptying may experience exacerbated symptoms with high-fiber preloads and should focus on easily digestible proteins and healthy fats instead.
  • Individuals with eating disorders or history of restrictive eating require careful psychological evaluation before implementing any structured eating protocols.
  • Patients taking medications affecting glucose homeostasis (insulin, sulfonylureas) may require dose adjustments when implementing meal sequencing strategies, as improved glucose control may reduce medication requirements.
  • Healthcare Provider Training and Support
    Successful implementation requires healthcare provider education on the physiological mechanisms and practical applications of these protocols. Key training elements should include: understanding of incretin physiology and gastric emptying regulation, recognition of refeeding syndrome risk factors and prevention strategies, practical meal sequencing guidance for diverse cultural dietary patterns, and monitoring strategies for patients implementing these interventions.
  • Technology Integration and Monitoring
    Continuous glucose monitoring (CGM) technology offers unprecedented opportunities to personalize and optimize these interventions. Real-time glucose feedback allows individuals to observe the direct effects of meal sequencing strategies, potentially enhancing adherence and enabling fine-tuning of approaches based on individual responses [69]. Mobile applications can support protocol adherence by providing meal timing reminders, food sequencing guidance, and progress tracking. The integration of these tools with healthcare provider monitoring systems could enable more personalized and effective implementation of these evidence-based strategies.

Future Research Directions and Limitations

Current Evidence Limitations

While the available evidence demonstrates consistent short-term benefits of meal sequencing and structured refeeding protocols, several limitations warrant acknowledgment. Many studies have relatively small sample sizes and short duration, limiting the ability to assess long-term effects and clinical outcomes. The majority of meal sequencing research has been conducted in Asian populations, raising questions about generalizability to Western dietary patterns and populations.

Additionally, the optimal timing intervals between food components, the effects of different protein sources, and the interaction between meal sequencing and various medications require further investigation.

Emerging Research Opportunities

Future research should focus on several key areas:

  • Long-term clinical outcomes: Randomized controlled trials of at least 12 months duration examining cardiovascular events, diabetes progression, and quality of life measures.
  • Personalized approaches: Investigation of genetic, microbiome, and metabolic factors that may predict individual responses to these interventions.
  • Mechanistic studies: Detailed examination of the interplay between gastric emptying, incretin secretion, and glucose homeostasis using advanced physiological measurement techniques.
  • Cultural adaptation: Development and testing of meal sequencing protocols adapted to diverse cultural dietary patterns and food preparation methods.
  • Economic evaluation: Cost-effectiveness analyses comparing these interventions to standard pharmaceutical approaches for diabetes prevention and management.

Conclusions

The evidence comprehensively supports the implementation of structured meal sequencing and safe refeeding protocols as effective, accessible interventions for optimizing metabolic health. The physiological mechanisms underlying these approaches are well-established, involving coordinated effects on gastric emptying, incretin hormone secretion, and glucose homeostasis.

Key clinical recommendations based on the reviewed evidence include:

  1. Meal sequencing following the vegetables/fiber → protein/fat → carbohydrates pattern consistently reduces postprandial glucose.
  2. Apple cider vinegar supplementation (5-15 mL diluted in water, 15-30 minutes pre-meal) provides significant improvements in glycemic control with minimal side effects.
  3. Intermittent fasting combined with protein pacing offers superior outcomes compared to continuous calorie restriction, with enhanced weight loss, improved body composition, and beneficial gut microbiome changes.
  4. Structured refeeding protocols emphasizing gradual food reintroduction and carbohydrate avoidance during initial phases provide safe approaches to breaking fasts of any duration.
  5. Integration of these approaches creates synergistic effects that optimize metabolic flexibility, enhance satiety, and improve long-term adherence to healthy eating patterns.

These evidence-based strategies offer healthcare providers and patients practical, cost-effective tools for metabolic health optimization. Unlike pharmaceutical interventions, these approaches carry minimal risk profiles while providing benefits that extend beyond glucose control to include weight management, cardiovascular health, and gut microbiome optimization.

The accessibility and simplicity of these interventions make them particularly valuable in addressing the global burden of metabolic disease. As research continues to refine our understanding of optimal implementation strategies, meal sequencing and structured refeeding protocols are positioned to become cornerstone interventions in preventive and therapeutic approaches to metabolic health management.

The integration of modern technology, including continuous glucose monitoring and mobile health applications, offers unprecedented opportunities to personalize these interventions and enhance their effectiveness. As we advance toward precision nutrition approaches, the fundamental principles elucidated by this research provide a solid foundation for individualized metabolic health optimization strategies.

Future clinical practice guidelines should incorporate these evidence-based approaches alongside traditional dietary counseling, recognizing that how and when we eat may be as important as what we consume in achieving optimal metabolic health outcomes.

References

  1. Hossain MdJ, Al‐Mamun Md, Islam MdR. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep; 7. Epub ahead of print 22 March 2024. DOI: 10.1002/hsr2.2004.
  2. Shukla AP, Dickison M, Coughlin N, et al. The impact of food order on postprandial glycaemic excursions in prediabetes. Diabetes Obes Metab 2019; 21: 377–381.
  3. Peters B, Vahlhaus J, Pivovarova-Ramich O. Meal timing and its role in obesity and associated diseases. Front Endocrinol (Lausanne); 15. Epub ahead of print 22 March 2024. DOI: 10.3389/fendo.2024.1359772.
  4. Chamorro R, Kannenberg S, Wilms B, et al. Meal Timing and Macronutrient Composition Modulate Human Metabolism and Reward-Related Drive to Eat. Nutrients 2022; 14: 562.
  5. Nauck MA, Niedereichholz U, Ettler R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. American Journal of Physiology-Endocrinology and Metabolism 1997; 273: E981–E988.
  6. Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab 2024; 110: 1–15.
  7. Marathe CS, Rayner CK, Jones KL, et al. Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones. Diabetes Care 2013; 36: 1396–1405.
  8. Horowitz M, Wu T, Rayner CK, et al. Spontaneous or Deliberate: Effects of Acute Variations in Glycemia on Gastric Emptying in Type 1 Diabetes. Diabetes Care 2021; 44: 316–318.
  9. Goyal RK, Guo Y, Mashimo H. Advances in the physiology of gastric emptying. Neurogastroenterology and motility 2019; 31: e13546.
  10. Doran S, Jones KL, Andrews JM, et al. Effects of meal volume and posture on gastric emptying of solids and appetite. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 1998; 275: R1712–R1718.
  11. Gutzwiller J-P, Drewe J, Ketterer S, et al. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2000; 279: R189–R195.
  12. French SJ, Murray B, Rumsey RDE, et al. Is cholecystokinin a satiety hormone? Correlations of plasma cholecystokinin with hunger, satiety and gastric emptying in normal volunteers. Appetite 1993; 21: 95–104.
  13. Grundy MM-L, Edwards CH, Mackie AR, et al. Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism. Br J Nutr 2016; 116: 816–33.
  14. Murillo S, Mallol A, Adot A, et al. Culinary strategies to manage glycemic response in people with type 2 diabetes: A narrative review. Front Nutr 2022; 9: 1025993.
  15. Liu QK. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. Front Endocrinol (Lausanne); 15. Epub ahead of print 24 July 2024. DOI: 10.3389/fendo.2024.1431292.
  16. Gautier J, Fetita S, Sobngwi E, et al. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 2005; 31: 233–242.
  17. Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig 2010; 1: 8–23.
  18. Alzahrani A, Alshobragi G, Alshehri A, et al. Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity. Integr Pharm Res Pract 2025; Volume 14: 59–72.
  19. Zheng Z, Zong Y, Ma Y, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther 2024; 9: 234.
  20. Yoder SM, Yang Q, Kindel TL, et al. Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 299: G476–G485.
  21. Nauck MA, Quast DR, Wefers J, et al. The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update. Diabetes Obes Metab 2021; 23: 5–29.
  22. Lee CJ, Brown TT, Cheskin LJ, et al. Effects of meal composition on postprandial incretin, glucose and insulin responses after surgical and medical weight loss. Obes Sci Pract 2015; 1: 104–109.
  23. Mishra S, Singh B. Intermittent Fasting and Metabolic Switching: A Brief Overview. Biomedical and Pharmacology Journal 2020; 13: 1555–1562.
  24. Smith RL, Soeters MR, Wüst RCI, et al. Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr Rev 2018; 39: 489–517.
  25. Anton SD, Moehl K, Donahoo WT, et al. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity (Silver Spring) 2018; 26: 254–268.
  26. Zamir MA. Aerobic Exercise in the Fasted State: the Effects on Energy Metabolism in Healthy Adults. International Journal of Sport, Exercise and Health Research 2022; 6: 55–62.
  27. Song D-K, Kim Y-W. Beneficial effects of intermittent fasting: a narrative review. Journal of Yeungnam Medical Science 2023; 40: 4–11.
  28. Palmer BF, Clegg DJ. Metabolic Flexibility and Its Impact on Health Outcomes. Mayo Clin Proc 2022; 97: 761–776.
  29. Çukurovalı Soykurt S, Tekdemir SN. Intermittent Fasting and Its Potential Effects on Health. Cyprus Journal of Medical Sciences 2024; 221–227.
  30. Obeid OA, Hachem DH, Ayoub JJ. Refeeding and metabolic syndromes: two sides of the same coin. Nutr Diabetes 2014; 4: e120–e120.
  31. Reber E, Friedli N, Vasiloglou MF, et al. Management of Refeeding Syndrome in Medical Inpatients. J Clin Med 2019; 8: 2202.
  32. Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ 2008; 336: 1495–1498.
  33. Shaheen A, Sadiya A, Mussa B, et al. Postprandial Glucose and Insulin Response to Meal Sequence Among Healthy UAE Adults: A Randomized Controlled Crossover Trial. Diabetes, Metabolic Syndrome and Obesity 2024; Volume 17: 4257–4265.
  34. Fazal MO, Abbas G, Yaqoob Y, et al. The postprandial glucose-lowering effect of dietary fiber (Psyllium Husk) in patients with type 2 diabetes mellitus. The Professional Medical Journal 2024; 31: 371–378.
  35. Giuntini EB, Sardá FAH, de Menezes EW. The Effects of Soluble Dietary Fibers on Glycemic Response: An Overview and Futures Perspectives. Foods; 11. Epub ahead of print 6 December 2022. DOI: 10.3390/foods11233934.
  36. Smedegaard S, Kampmann U, Ovesen PG, et al. Whey Protein Premeal Lowers Postprandial Glucose Concentrations in Adults Compared with Water—The Effect of Timing, Dose, and Metabolic Status: a Systematic Review and Meta-analysis. Am J Clin Nutr 2023; 118: 391–405.
  37. Connolly G, Wang Y, Bergia RE, et al. Whey Protein Supplementation and Type 2 Diabetes Mellitus Risk Factors: An Umbrella Systematic Review of Randomized Controlled Trials. Curr Dev Nutr 2023; 7: 102017.
  38. Sridonpai P, Prachansuwan A, Praengam K, et al. Postprandial effects of a whey protein-based multi-ingredient nutritional drink compared with a normal breakfast on glucose, insulin, and active GLP-1 response among type 2 diabetic subjects: a crossover randomised controlled trial. J Nutr Sci 2021; 10: e49.
  39. Neeland IJ, de Gregório LH, Zagury R, et al. A Randomized, Placebo-Controlled, Single-Center, Crossover Study to Evaluate the Effects of Pre-Meal Whey Protein Microgel on Post-Prandial Glucometabolic and Amino Acid Response in People with Type 2 Diabetes and Overweight or Obesity. Metabolites 2025; 15: 61.
  40. Ma J, Stevens JE, Cukier K, et al. Effects of a Protein Preload on Gastric Emptying, Glycemia, and Gut Hormones After a Carbohydrate Meal in Diet-Controlled Type 2 Diabetes. Diabetes Care 2009; 32: 1600–1602.
  41. Gentilcore D, Chaikomin R, Jones KL, et al. Effects of Fat on Gastric Emptying of and the Glycemic, Insulin, and Incretin Responses to a Carbohydrate Meal in Type 2 Diabetes. J Clin Endocrinol Metab 2006; 91: 2062–2067.
  42. Samms RJ, Coghlan MP, Sloop KW. How May GIP Enhance the Therapeutic Efficacy of GLP-1? Trends in Endocrinology & Metabolism 2020; 31: 410–421.
  43. McClean PL, Irwin N, Cassidy RS, et al. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 2007; 293: E1746–E1755.
  44. Mells JE, Anania FA. The role of gastrointestinal hormones in hepatic lipid metabolism. Semin Liver Dis 2013; 33: 343–57.
  45. Kurotobi Y, Kuwata H, Matsushiro M, et al. Sequence of Eating at Japanese-Style Set Meals Improves Postprandial Glycemic Elevation in Healthy People. Nutrients 2025; 17: 658.
  46. Imai S, Fukui M, Kajiyama S. Effect of eating vegetables before carbohydrates on glucose excursions in patients with type 2 diabetes. J Clin Biochem Nutr 2014; 54: 7–11.
  47. Gerontiti E, Shalit A, Stefanaki K, et al. The role of low glycemic index and load diets in medical nutrition therapy for type 2 diabetes: an update. Hormones (Athens) 2024; 23: 655–665.
  48. Zafar MI, Mills KE, Zheng J, et al. Low-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis. Am J Clin Nutr 2019; 110: 891–902.
  49. Kaur B, Koh M, Ponnalagu S, et al. Postprandial blood glucose response: does the glycaemic index (GI) value matter even in the low GI range? Nutr Diabetes 2020; 10: 15.
  50. Alkay Z, Falah F, Cankurt H, et al. Exploring the Nutritional Impact of Sourdough Fermentation: Its Mechanisms and Functional Potential. Foods; 13. Epub ahead of print 31 May 2024. DOI: 10.3390/foods13111732.
  51. Islam MA, Islam S. Sourdough Bread Quality: Facts and Factors. Foods 2024; 13: 2132.
  52. Fatema K, Begum D, Hossain F, et al. Effects of Apple Cider Vinegar on Glycemic Status in Type 2 Diabetes Mellitus. American Journal of Pure and Applied Biosciences 2025; 7: 235–241.
  53. Arjmandfard D, Behzadi M, Sohrabi Z, et al. Effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes: A GRADE-assessed systematic review and dose–response meta-analysis of controlled clinical trials. Front Nutr; 12. Epub ahead of print 30 January 2025. DOI: 10.3389/fnut.2025.1528383.
  54. Mohr AE, Sweazea KL, Bowes DA, et al. Gut microbiome remodeling and metabolomic profile improves in response to protein pacing with intermittent fasting versus continuous caloric restriction. Nat Commun 2024; 15: 4155.
  55. Tzeravini E, Anastasios T, Alexander K, et al. Diet induced thermogenesis, older and newer data with emphasis on obesity and diabetes mellitus – A narrative review. Metabol Open 2024; 22: 100291.
  56. Tavella T, Rampelli S, Guidarelli G, et al. Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes 2021; 13: 1–19.
  57. Goodrich JK, Waters JL, Poole AC, et al. Human Genetics Shape the Gut Microbiome. Cell 2014; 159: 789–799.
  58. Lei S, Liu G, Wang S, et al. Intermittent Fasting Improves Insulin Resistance by Modulating the Gut Microbiota and Bile Acid Metabolism in Diet‐Induced Obesity. Mol Nutr Food Res; 68. Epub ahead of print 9 November 2024. DOI: 10.1002/mnfr.202400451.
  59. Gumpricht E, Mohr AE, Sweazea KL, et al. Intermittent Fasting and Protein Pacing Adherence Maintains 100 Pound Weight Loss for Two Years: A Case Study. Curr Dev Nutr 2025; 9: 107220.
  60. Engevik AC, Kaji I, Goldenring JR. The Physiology of the Gastric Parietal Cell. Physiol Rev 2020; 100: 573–602.
  61. Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab 2014; 19: 181–92.
  62. Dai Z, Zhang H, Sui X, et al. Analysis of physiological and biochemical changes and metabolic shifts during 21-Day fasting hypometabolism. Sci Rep 2024; 14: 28550.
  63. Malone JC, Thavamani A. Physiology, Gastrocolic Reflex. StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK549888/ (2023, accessed 14 September 2025).
  64. Ng C, Danta M, Prott G, et al. Modulatory influences on antegrade and retrograde tonic reflexes in the colon and rectum. American Journal of Physiology-Gastrointestinal and Liver Physiology 2004; 287: G962–G966.
  65. De Silva A, Nightingale JMD. Refeeding syndrome : physiological background and practical management. Frontline Gastroenterol 2020; 11: 404–409.
  66. Rio A, Whelan K, Goff L, et al. Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open 2013; 3: e002173.
  67. Persaud-Sharma D, Saha S, Trippensee AW. Refeeding Syndrome. StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK564513/ (2022, accessed 14 September 2025).
  68. Chiappetta S, Stein J. Refeeding Syndrome: An Important Complication Following Obesity Surgery. Obes Facts 2016; 9: 12–6.
  69. Song J, Oh TJ, Song Y. Individual Postprandial Glycemic Responses to Meal Types by Different Carbohydrate Levels and Their Associations with Glycemic Variability Using Continuous Glucose Monitoring. Nutrients 2023; 15: 3571.